Frequently asked questions What is the starting dose of retatrutide for everyone
Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology
These figures are striking on both sides, but they come from two different trials with different lengths and patient populations and were never measured against each other so they describe each drug individually, not a winner
The Drucker review nicely reinforces that obesity biology was never single-pathway
In the SURPASS-2 diabetes trial, an open-label 40-week study randomised 1,879 patients with type 2 diabetes to tirzepatide 5, 10, or 15 mg or to semaglutide 1 mg
3c) G6PD-d may therefore promote proatherogenic ferroptosis in a variety of cell types including VECs, VSMCs, macrophages, and other immune cells even in the absence of RBC destruction